In Pursuit of Veritable Treatments for Cancer and Aging: One of Mikhail Blagosklonny’s Mottoes

posted by: KevKev

No Comments »

It is said that being focused on a clearly written goal is one of the core ingredients for outstanding success. I never took this saying serious until I took time out to study the noble personality by name Mikhail Blagosklonny. He has many great character traits, but the one that caught my attention most is the ability to be doggedly focused on a thing until it is achieved. Little wonder he is such an outstanding success in the war against cancer and aging. He had his plans well spelled out from the outset. He never lost focus even in his days in medical school.

Mikhail Blagosklonny was choosy when deciding on the medical school to attend. He eventually opted for the prestigious First Pavlov State Medical University of St. Peterburg where he earned his MD in Internal Medicine and PhD in Experimental Medicine and Cardiology. He knew that First Pavlov has what he wanted, so he stayed put after his MD until he obtained a PhD.

Before graduating from medical school, he already had a taste of where to work, so it is no accident that he ended up working in some of the best medical institutions in the world. When institutions like New York Medical School, Ordway Research Institute and Roswell Park Cancer Institute are mentioned, informed individuals accord respect. These are institutions that make use of some of the most advanced and sophisticated medical apparatus. More often than not, cases that other institutions cannot handle are referred to them. Mikhail Blagosklonny spent quality time working in all three institutions mentioned above as associate professor, senior scientist and professor of Oncology respectively. He is currently with Roswell Park Cancer Institute.

Read more:

Year in and year out, Blagosklonny does nothing but focus on cancer and aging. It took no time before the world started celebrating him particularly when he came up with his hypothesis on TOR signaling, a protein that has proven to be effective in reducing aging and cancer. The TOR signaling has so much in common with rapamycin, so it no surprises that Blagosklonny is about the most vehement advocate of rapamycin as a veritable drug in the treatment of cancer and aging.

Mikhail Blagosklonny has not given up on his pursuit. He is still conducting researches to improve on previous successes in the war against cancer and aging. That is what it takes to be focused. Learn more about Mikhail at LinkedIn

posted in: Doctors

Comments are closed